Publicaciones en colaboración con investigadores/as de Centro de Investigación Príncipe Felipe (18)

2024

  1. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination

    Cell Communication and Signaling, Vol. 22, Núm. 1

  2. Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma

    Molecular Oncology, Vol. 18, Núm. 1, pp. 190-215

2023

  1. A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients

    Annals of Surgical Oncology, Vol. 30, Núm. 2, pp. 1225-1235

  2. Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer

    Cancers, Vol. 14, Núm. 13

2021

  1. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  2. The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18

2020

  1. A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer

    Expert Review of Molecular Diagnostics, Vol. 20, Núm. 6, pp. 575-582

  2. Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR

    Frontiers in Medicine, Vol. 7

2019

  1. Exosomes in NSCLC: Analysis of its cargo as a source of biomarkers

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, pp. ii10-ii11

  2. Interplay between microRNAs and oxidative stress in ovarian conditions with a focus on ovarian cancer and endometriosis

    International Journal of Molecular Sciences, Vol. 20, Núm. 21

  3. Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer

    Cell Death and Disease, Vol. 10, Núm. 9

2018

  1. An expression signature characterizes cancer stem cells from lung adenocarcinoma patients

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii666

  2. High-throughput screening of new drugs targeting lung CSCs

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii668

2017

  1. MicroRNA profiling associated with non-small cell lung cancer: Next generation sequencing detection, experimental validation, and prognostic value

    Oncotarget, Vol. 8, Núm. 34, pp. 56143-56157

2016

  1. 114P: Expression analysis of tumorspheres from non-small cell lung cancer show significant differences in CSC-markers and signaling pathways

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S105

  2. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer

    Oncotarget, Vol. 7, Núm. 11, pp. 12904-12916

2015

  1. Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells

    Journal of the American Chemical Society, Vol. 137, Núm. 50, pp. 15892-15898